-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CD56 Enriched Donor Lymphocyte Infusion in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CD56 Enriched Donor Lymphocyte Infusion in Mantle Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CD56 Enriched Donor Lymphocyte Infusion in Mantle...
-
Sector Analysis
Infusion Pump Disposables Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Infusion Pump Disposables Market Report Overview The infusion pump disposables market size was valued at $3.92 billion in 2023 and will grow at a CAGR of more than 3% from 2023 to 2033. The primary factor driving the market growth is the rise in chronic disorders such as heart disease, heart stroke, cancer, and diabetes. The rising incidence rate of such diseases has resulted in extensive use of infusion pumps for patients in ICU, chemotherapy patients, and patients requiring multiple...
-
Product Insights
Infusion Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Infusion Systems Pipeline Market Report Overview Infusion systems are used to administer medication to a patients in critical care, emergency care, home care, and trauma centres. The infusion systems pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials....
-
Sector Analysis
Infusion Pumps Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Infusion Pumps Market Overview The infusion pumps market size was valued at $2.64 billion in 2023. The infusion pumps market will grow at a CAGR of more than 2% from 2023 to 2033. The infusion pump is a commonly used medical device for patients with chronic conditions such as cancer and diabetes used at hospitals, homes, and healthcare centers. Infusion pumps successfully address the delivery-related problems that have serious implications on patient safety, with their ability to administer fluids, medication,...
-
Product Insights
Infusion Pumps Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Infusion Pumps Pipeline Market Report Overview Infusion Pumps are the drug delivery system that provides continuous infusion of an agent at a constant and precise rate. The Infusion Pumps pipeline market research report provides comprehensive information about the Infusion Pumps pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Territories ·       The US ·       Global ·       Israel ·       Singapore ·       Japan Key Regulatory Paths...
-
Product Insights
NewLikelihood of Approval Analysis for Idiopathic Inflammatory Myopathy (IIM)
Overview How likely is it that the drugs in Idiopathic Inflammatory Myopathy (IIM) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Idiopathic Inflammatory Myopathy (IIM) Overview Inflammation of muscle is known...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lifileucel in Recurrent Head And Neck Squamous Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lifileucel in Recurrent Head And Neck Squamous Cell Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lifileucel in Recurrent Head And Neck...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lifileucel in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lifileucel in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lifileucel in Non-Small Cell Lung Cancer Drug Details: Lifileucel...
-
Product Insights
NewLikelihood of Approval Analysis for Acute Coronary Syndrome
Overview How likely is it that the drugs in Acute Coronary Syndrome will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acute Coronary Syndrome Overview Acute coronary syndrome (ACS) encompasses ST-elevation myocardial...
-
Product Insights
NewLikelihood of Approval Analysis for Stem Cell Transplantation
Overview How likely is it that the drugs in Stem Cell Transplantation will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Stem Cell Transplantation Overview Stem cell transplantation, also known as hematopoietic...